A familial amyotrophic lateral sclerosis pedigree discordant for a novel p.Glu46Asp heterozygous OPTN variant and the p.Ala5Val heterozygous SOD1 missense mutation.


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
May 2020
Historique:
received: 10 01 2020
accepted: 20 03 2020
pubmed: 1 4 2020
medline: 30 9 2020
entrez: 1 4 2020
Statut: ppublish

Résumé

About 10% of Amyotrophic Lateral Sclerosis (ALS) cases are familial (FALS), mainly related to mutations in C9ORF72, SOD1, TARDBP, and FUS genes. Recent data revealed the presence of multiple variants in ALS-associated genes in FALS in excess of what is to be expected by chance. FALS patients not carrying a pathogenic genetic mutation detected in their kindred have been reported. We report a FALS case, who did not carry the p.Ala5Val heterozygous SOD1 mutation that had been detected in other affected subjects of his kindred. He underwent Next-Generation Sequencing, revealing a novel p.Glu46Asp heterozygous OPTN variant of uncertain significance (VUS). Discordant genetic test results in FALS cases within the same family and the detection of variants of uncertain significance increase the complexities of genetic counselling.

Identifiants

pubmed: 32223976
pii: S0967-5868(20)30095-3
doi: 10.1016/j.jocn.2020.03.032
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0
Membrane Transport Proteins 0
OPTN protein, human 0
SOD1 protein, human 0
Glutamine 0RH81L854J
Aspartic Acid 30KYC7MIAI
Superoxide Dismutase-1 EC 1.15.1.1
Valine HG18B9YRS7
Alanine OF5P57N2ZX

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

223-225

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Antonio Canosa (A)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy; Azienda Ospedaliero Universitaria Città della Salute e della Scienza, SC Neurologia 1U, Turin, Italy. Electronic address: antonio.canosa@unito.it.

Maurizio Grassano (M)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Marco Barberis (M)

Azienda Ospedaliero Universitaria Città della Salute e della Scienza, SC Genetica Medica U, Turin, Italy.

Maura Brunetti (M)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Umberto Manera (U)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Rosario Vasta (R)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Stefania Cammarosano (S)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Giovanni De Marco (G)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Andrea Calvo (A)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy; Azienda Ospedaliero Universitaria Città della Salute e della Scienza, SC Neurologia 1U, Turin, Italy; Neuroscience Institute of Turin (NIT), Turin, Italy.

Adriano Chiò (A)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy; Azienda Ospedaliero Universitaria Città della Salute e della Scienza, SC Neurologia 1U, Turin, Italy; Neuroscience Institute of Turin (NIT), Turin, Italy; Institute of Cognitive Sciences and Technologies, Consiglio Nazionale delle Ricerche, Rome, Italy.

Cristina Moglia (C)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy; Azienda Ospedaliero Universitaria Città della Salute e della Scienza, SC Neurologia 1U, Turin, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH